US FDA Declines to Approve Viatris ' s Injection for Multiple Sclerosis US FDA Declines to Approve Viatris ' s Injection for Multiple Sclerosis

The U.S. FDA has declined to approve Viatris and Mapi Pharma ' s once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis...Reuters Health Information
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery Source Type: news